MECHANISM OF ORAL SEMAGLUTIDE DELIVERY Oral delivery of peptide-derived drugs is often ineffective due to proteolytic degradation within the gastrointestinal tract leading to subtherapeutic drug exposure
SNAC functions through a multifaceted mechanism: it buffers the local gastric pH, thereby protecting semaglutide from acidic degradation and proteolytic enzymes, and enhances drug solubility and monomerization
It was approved by the FDA under the trade name Adlyxin in 2016 and launched in China in January 2018
Even within a regulated study, GLP-1 materials should be sourced only from authorized suppliers, with appropriate storage, chain-of-custody records, temperature logs, informed consent language and IRB oversight
Inadequate hydration and electrolyte losses from reduced food intake and nausea can also trigger muscle cramps and back tension
Healthcare providers should be aware of these risks and monitor patients closely